Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: a qualitative study

Lee, Iyn Hyang; Rhie, Sandy Jeong; Je, Nam Kyung; Rhew, Ki Yon; Ji, Eunhee; Oh, Jung Mi; Lee, Euni; Yoon, Jeong Hyun

doi:10.1007/s11096-016-0355-9

Cited by 17 publications

(40 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This descriptive study demonstrated that clinical pharmacists' collaboration with physicians and nurses in hospital increased patient safety and improved the quality of prescribing and that doctors perceived this collaboration as beneficial both for themselves and their patients [23]. In a study, from South Korea, the nurses interviewed discussed the need for pharmacists in improving communication, drug counselling, providing information about drug distribution in the market, implementing an easy-to-use drug identification system, providing a medication reconciliation service and providing education to nurses about medications [25]. In the study by Salgado et al, nurses from Australia and Portugal were interviewed and whilst Australian nurses were aware of the clinical competencies of pharmacists, in contrast, Portuguese nurses appeared to have little knowledge of pharmacists competencies [26].…”

Section: Introductionmentioning

confidence: 99%

The Role of the Clinical Pharmacist in an Irish University Teaching Hospital: A Mixed-Methods Study

et al. 2020

View full text Add to dashboard Cite

Medication review (MR) is a vital part of the pharmacist’s role in hospital. However, in the South Infirmary Victoria University Hospital (SIVUH), Cork, Ireland, this has not been fully implemented due to resource issues. In addition, the cost of providing this service has not been evaluated. Moreover, it is not clear how other members of the multidisciplinary team e.g., Nurses, value any interventions made as a result of the MR. This mixed methods study assessed the impact of MR in terms of (i) potential clinical harm, (ii) cost avoidance and (iii) the views of nursing staff on the role of the pharmacist. The setting is a 192-bed, voluntary, acute hospital, in the Munster region of Ireland. Study I: The pharmacist provided MR to patients conventionally once a week. Any interventions were then assessed for potential clinical harm and to calculate cost avoidance. Study II: Semi-structured interviews, guided by a topic guide were completed with 12 nurses (11 female). Thematic analysis was used to code the main themes. Main outcome measure: To estimate the cost, cost avoidance, and the net cost benefit ratio of MR provided by pharmacists. Study I: Of 128 patients who received the MR, 113 interventions were made. The estimated cost of providing the MR was €2559 (senior pharmacist). Using €1084 as the cost of an adverse drug event (ADE), the cost avoidance was calculated at €42,330. This led to a net cost benefit of €39,771 (senior pharmacist) which equated to a net cost benefit ratio of 16.5:1. Study II: The main themes were (i) perceptions of pharmacy services, (ii) the role of the pharmacist—past, present and future, and (iii) teamwork and communication. Nurses expressed a desire to have more pharmacists present on the wards.

show abstract

Section: Introductionmentioning

confidence: 99%

The Role of the Clinical Pharmacist in an Irish University Teaching Hospital: A Mixed-Methods Study

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The “customer journey maps” allowed us to see which parts of the service might need improvement ( Fig 2 ) [ 16 ]. Finally, we conducted focus group discussions and in-depth interviews with 18 physicians and 15 nurses to gather information about their interests and discomfort in current services, as well as their expectations for new MTC services [ 10 ]. We also completed face-to-face surveys with 219 patients and focused on identifying their needs for improved MTC services [ 10 , 17 ].…”

Section: Methodsmentioning

confidence: 99%

“…However, in South Korea, the development of MTC service is in the beginning stages, and healthcare professionals still independently provide services to patients. Furthermore, services in hospital pharmacies are limited to medication counseling, anticoagulation counseling, therapeutic drug monitoring, and similar services, despite the high risk of medication-related problems [ 10 ]. For this reason, advanced pharmaceutical care services for patients who may have medication-related problems are in high demand.…”

Section: Introductionmentioning

confidence: 99%

Service design oriented multidisciplinary collaborative team care service model development for resolving drug related problems

Han

Chu

et al. 2018

PLoS ONE

Self Cite

View full text Add to dashboard Cite

Our goal was to help prevent drug-related morbidity and mortality by developing a collaborative multidisciplinary team care (MTC) service model using a service design framework that addressed the unmet needs and perspectives of diverse stakeholders. Our service model was based on a “4D” framework that included Discover, Define, Design, and Develop phases. In the “discover” phase, we conducted desk research and field research of stakeholders to identify the unmet needs in existing patient care services. We used service design tools, including service safaris, user shadowing, and customer journey maps to identify pain and opportunity points in the current services. We also performed focus group discussions and in-depth interviews with stakeholders to explore the needs for improved services. In the “define” phase, we generated the service concept by mind mapping and brainstorming about the needs of stakeholders. The service concept was defined to be a Patient-oriented, Collaborative, Advanced, Renovated, and Excellent (P-CARE) service. We named the service “DrugTEAM” (Drug Therapy Evaluation And Management). In the “design” phase, we designed and refined four prototypes based on results from validation tests for their application towards following services: 1) medication reconciliation, 2) medication evaluation and management, 3) evidence-based drug information, and 4) pharmaceutical care transition services. During the “develop” phase, we implemented four services in a longitudinal chronic care model, considering the time spent by patients for each inpatient and outpatient setting. In conclusion, this is a study to develop a collaborative MTC service model using service design framework, focused on managing the unmet needs of patients and healthcare providers. As a result of implementing this service model, we expect to strengthen the professional relationship between pharmacists and stakeholders to ultimately create better patient outcomes.

show abstract

“…We previously published the qualitative analyses of the PCS needs by health care providers and this study focused on PCSs with patients’ perspectives. 21 …”

Section: Methodsmentioning

confidence: 99%

“…A questionnaire was preformulated by facts clustering, opportunity web, and mind map processes so that various matrices of PCSs could be completed. 21 The prototype questionnaire had consisted of eleven satisfaction and eleven expressed needs. We held focus group discussions with clinical pharmacists with PCSs experiences and pharmacy school faculties, and conducted focused individual interviews with physician specialists and registered nurses.…”

Section: Methodsmentioning

confidence: 99%

Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea

Kang¹,

Rhew²,

Oh³

et al. 2017

PPA

Self Cite

View full text Add to dashboard Cite

PurposeTo assess the degree of satisfaction and expressed needs of pharmaceutical care services in patients with chronic diseases and explore the factors related to the needs from patients’ perspectives for the further development of pharmaceutical care service models.Patients and methodsA cross-sectional survey of 220 patients (mean age ± SD: 61.3±13.1, male:female: 104:116) was conducted. The questionnaire was structured to measure patients’ degree of satisfaction and expressed needs using a 5-point Likert scale. Additionally, preferred duration, methods of service delivery, and willingness to pay were surveyed. Responses were analyzed using an ordinal regression method to predict factors that were related to pharmaceutical care services.ResultsSixty-seven patients had experienced pharmaceutical care services. Their satisfaction levels were high in all categories; however, there were no significant differences between categories. The levels of expressed needs were similar among categories without significant differences. The preferred delivery method was a face-to-face conversation combined with being provided with written information (53.2%). The preferred duration was ≤10 min (70.5%). About 48% of the patients showed willingness to pay for the service. Education level and region influenced patients’ needs.ConclusionThe satisfaction and needs of pharmaceutical care services was very positive; however, noticing only a third of patients experienced pharmaceutical care services, this may indicate a lack of awareness and less appreciation of pharmacists by patients. Details concerning patients’ awareness and the value of pharmaceutical care services require further investigation.

show abstract

Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: a qualitative study

Cited by 17 publications

References 33 publications

The Role of the Clinical Pharmacist in an Irish University Teaching Hospital: A Mixed-Methods Study

The Role of the Clinical Pharmacist in an Irish University Teaching Hospital: A Mixed-Methods Study

Service design oriented multidisciplinary collaborative team care service model development for resolving drug related problems

Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea

Contact Info

Product

Resources

About